Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation
- PMID: 2551925
- PMCID: PMC329787
- DOI: 10.1172/JCI114294
Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation
Abstract
The reduction of myocardial beta-adrenoceptor density in congestive heart failure has been thought to be caused by agonist-induced homologous desensitization. However, recent evidence suggests that excessive adrenergic stimulation may not produce myocardial beta-receptor downregulation unless there is an additional defect in the local norepinephrine (NE) uptake mechanism. To investigate the association between beta-adrenoceptor regulation and NE uptake activity, we carried out studies in 30 dogs with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary artery constriction and 23 sham-operated control dogs. We determined NE uptake activity by measuring accumulation of [3H]NE in tissue slices, NE uptake-1 carrier density by [3H]mazindol binding and beta-adrenoceptor density by [3H]dihydroalprenolol binding. Compared with sham-operated dogs, RHF dogs showed a 26% decrease in beta-adrenoceptor density, a 51% reduction in NE uptake activity, and a 57% decrease in NE uptake-1 carrier density in their right ventricles. In addition, right ventricle beta-receptor density correlated significantly with NE uptake activity and NE uptake-1 carrier density. In contrast, neither NE uptake activity nor beta-receptor density in the left ventricle and renal cortex was affected by RHF. Thus, the failing myocardium is associated with an organ- and chamber-specific subnormal neuronal NE uptake. This chamber-specific loss of NE uptake-1 carrier could effectively reduce local NE clearance, and represent a local factor that predisposes the failing ventricle to beta-adrenoceptor downregulation.
Similar articles
-
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1863-72. doi: 10.1152/ajpheart.01131.2001. Am J Physiol Heart Circ Physiol. 2002. PMID: 12384464
-
Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.Circulation. 1993 Sep;88(3):1299-309. doi: 10.1161/01.cir.88.3.1299. Circulation. 1993. PMID: 8102598
-
Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.Eur J Pharmacol. 1987 Aug 11;140(2):123-32. doi: 10.1016/0014-2999(87)90798-9. Eur J Pharmacol. 1987. PMID: 2822436
-
Mechanisms of downregulation of beta-adrenergic receptors: perspective on the role of beta-adrenergic receptors in congestive heart failure.J Cardiovasc Pharmacol. 1989;14 Suppl 5:S13-8. J Cardiovasc Pharmacol. 1989. PMID: 2478805 Review.
-
[Catecholamines and beta-blockers for the treatment of heart failure].Nihon Rinsho. 1993 May;51(5):1268-75. Nihon Rinsho. 1993. PMID: 8101236 Review. Japanese.
Cited by
-
A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.J Neurosci. 2003 Mar 1;23(5):1697-709. doi: 10.1523/JNEUROSCI.23-05-01697.2003. J Neurosci. 2003. PMID: 12629174 Free PMC article.
-
Monoamine oxidases as sources of oxidants in the heart.J Mol Cell Cardiol. 2014 Aug;73:34-42. doi: 10.1016/j.yjmcc.2013.12.032. Epub 2014 Jan 9. J Mol Cell Cardiol. 2014. PMID: 24412580 Free PMC article. Review.
-
123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.J Nucl Cardiol. 2009 Jan-Feb;16(1):113-21. doi: 10.1007/s12350-008-9008-2. Epub 2009 Jan 20. J Nucl Cardiol. 2009. PMID: 19152136 Clinical Trial.
-
Medical management of congestive heart failure.West J Med. 1990 Oct;153(4):406-14. West J Med. 1990. PMID: 2244376 Free PMC article. Review.
-
Myocardial oxidative stress changes during compensated right heart failure in rats.Mol Cell Biochem. 1999 Jun;196(1-2):51-7. Mol Cell Biochem. 1999. PMID: 10448902
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical